INVIVO THERAPEUTICS HOLDINGS (NVIV)

US46186M6057 - Common Stock

0.3207  -0.17 (-34.28%)

After market: 0.231 -0.09 (-27.97%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2023-9-30)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash
60.00K60.00K10.00K-10.00K-20.00K
Cash Equivalents
8.52M16.30M19.03M19.51M6.62M
Marketable Securities
N/AN/AN/AN/AN/A
Other Current Assets
940.00K1.25M110.00K160.00K180.00K
Total Current Assets
9.53M17.60M19.14M19.66M6.78M
 
Non-Current Assets
PPE Net
10.00K1.07M1.36M1.01M1.28M
Intangibles
N/AN/A0.0010.00K30.00K
Other Non-Current Assets
50.00K150.00K1.27M1.23M1.23M
Total Non-Current Assets
50.00K1.22M2.63M2.25M2.55M
 
TOTAL ASSETS
9.58M18.82M21.77M21.91M9.33M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
N/AN/AN/AN/A0.00
Accrued Expenses
540.00K1.85M2.01M1.49M1.72M
Accounts Payable
120.00K620.00K610.00K480.00K940.00K
Other Current Liabilities
N/AN/AN/AN/AN/A
Total Current Liabilities
670.00K2.47M2.61M1.97M2.66M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
0.00610.00K1.04M750.00K1.08M
Total Non-Current Liabilities
0.00610.00K1.05M750.00K1.08M
 
TOTAL LIABILITIES
670.00K3.08M3.66M2.72M3.74M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-255.59M-248.62M-238.13M-228.23M-219.16M
Additional Paid In Capital
264.50M264.36M256.24M247.42M224.74M
Common Shares
0.000.000.000.000.00
Shares Outstanding
3.11M2.43M1.37M950.00K20.00K
Tangible Book Value per Share
2.876.4813.2320.19277.50
Total Shareholders' Equity
8.92M15.75M18.12M19.19M5.58M
 
TOTAL LIABILITIES AND EQUITY
9.58M18.82M21.77M21.91M9.33M
 
Statistics
Debt/Equity
N/AN/AN/AN/AN/A
Current Ratio
14.227.137.339.982.55
Return On Assets (ROA)
-97.39%-55.74%-45.48%-41.40%-126.80%
Return On Equity (ROE)
-104.60%-66.60%-54.64%-47.26%-212.01%

All data in USD

Charts